Tenax Therapeutics reports Q2 EPS ($1.83), consensus ($1.98)
PremiumThe FlyTenax Therapeutics reports Q2 EPS ($1.83), consensus ($1.98)
3M ago
Tenax announces plans to accelerate oral levosimendan Phase 3 program
Premium
The Fly
Tenax announces plans to accelerate oral levosimendan Phase 3 program
3M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
Tenax Therapeutics reports Q1 EPS ($3.12) vs. ($12.10) last year
PremiumThe FlyTenax Therapeutics reports Q1 EPS ($3.12) vs. ($12.10) last year
6M ago
TENX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
TENX Earnings this Week: How Will it Perform?
6M ago
Tenax Therapeutics announces new U.S. patent covering use of levosimendan
Premium
The Fly
Tenax Therapeutics announces new U.S. patent covering use of levosimendan
6M ago
Tenax Therapeutics Raises $9M in Public Offering and Warrants
PremiumCompany AnnouncementsTenax Therapeutics Raises $9M in Public Offering and Warrants
9M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
9M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100